These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 31010564)

  • 1. Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
    Jones HE; Kraft WK
    Clin Perinatol; 2019 Jun; 46(2):349-366. PubMed ID: 31010564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
    MacMillan KDL
    Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
    McPherson C
    Neonatal Netw; 2016; 35(5):314-20. PubMed ID: 27636696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National Guidance.
    Klaman SL; Isaacs K; Leopold A; Perpich J; Hayashi S; Vender J; Campopiano M; Jones HE
    J Addict Med; 2017; 11(3):178-190. PubMed ID: 28406856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of naltrexone in treating opioid use disorder in pregnancy.
    Towers CV; Katz E; Weitz B; Visconti K
    Am J Obstet Gynecol; 2020 Jan; 222(1):83.e1-83.e8. PubMed ID: 31376396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
    Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
    Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic opioid use during pregnancy: maternal and fetal implications.
    Stanhope TJ; Gill LA; Rose C
    Clin Perinatol; 2013 Sep; 40(3):337-50. PubMed ID: 23972743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of neonatal abstinence syndrome from opioids.
    Grim K; Harrison TE; Wilder RT
    Clin Perinatol; 2013 Sep; 40(3):509-24. PubMed ID: 23972754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
    O'Connor AB; Collett A; Alto WA; O'Brien LM
    J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
    Johnson S; Martin PR
    Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.
    Nguyen L; Lander LR; O'Grady KE; Marshalek PJ; Schmidt A; Kelly AK; Jones HE
    Am J Addict; 2018 Mar; 27(2):92-96. PubMed ID: 29473258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging therapies for the treatment of neonatal abstinence syndrome.
    Frazier LM; Bobby LE; Gawronski KM
    J Matern Fetal Neonatal Med; 2022 Mar; 35(5):987-995. PubMed ID: 32146833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone and buprenorphine for the management of opioid dependence in pregnancy.
    Jones HE; Finnegan LP; Kaltenbach K
    Drugs; 2012 Apr; 72(6):747-57. PubMed ID: 22512363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of the assessment and management of neonatal abstinence syndrome.
    Bagley SM; Wachman EM; Holland E; Brogly SB
    Addict Sci Clin Pract; 2014 Sep; 9(1):19. PubMed ID: 25199822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.